Tel Aviv University researchers suggest that carriers of the genetic mutations PiZ and PiS are at high risk for severe illness and even death from COVID-19. These mutations lead to deficiency in the alpha1-antitrypsin protein, which protects lung tissues from damage in case of severe infections. Other studies have already associated deficiency in this protein… Read More
Until now, seven genes were known to be involved in hearing loss in Israel’s Jewish population. A new study led by Zippora Brownstein, PhD, and Prof. Karen Avraham from the Sackler Faculty of Medicine at Tel Aviv University has found that 32 genes are responsible for inherited hearing loss in Israeli Jewish families. The researchers… Read More
Google.org, a Google fund aimed at supporting data based solutions for some of humanity’s greatest challenges, has awarded a competitive grant to Tel Aviv University for high-impact research employing Data Science and Artificial Intelligence (AI) to combat COVID-19. This step is one of many taken by Google in its ongoing effort to contribute to the… Read More
Researchers at Tel Aviv University (TAU) have analyzed 18 ancient texts dating back to around 600 BCE from the Tel Arad military post using state-of-the-art image processing, machine learning technologies, and the expertise of a senior handwriting examiner. They have concluded that the texts were written by no fewer than 12 authors, suggesting that many… Read More
Science-based technology company 3M has awarded a significant philanthropic research grant of $400,000 to the Shmunis School of Biomedicine and Cancer Research at Tel Aviv University (TAU) to advance scientific knowledge in the global response to the COVID-19 pandemic. The grant from 3M, which has its Israel operations in Herzliya, forms part of a $5… Read More
Researchers at Tel Aviv University, led by Prof. Ronit Satchi-Fainaro of TAU’s Department of Physiology and Pharmacology at the Sackler School of Medicine, have developed an innovative nanotechnological drug delivery system that significantly enhances the effectiveness of treatment for the aggressive skin cancer melanoma. The nanocarrier is a biocompatible and biodegradable polymer, which comprises repeating… Read More
A new Tel Aviv University study examined the brain’s reactions in conditions of uncertainty and stressful conflict in an environment of risks and opportunities. The researchers identified the areas of the brain responsible for the delicate balance between desiring gain and avoiding loss along the way. The study was led by TAU researchers Prof. Talma… Read More
On Wednesday, August 12, Tel Aviv University celebrated the inauguration of the Shmunis School of Biomedicine and Cancer Research. The new School, which belongs to the George S. Wise Faculty of Life Sciences, will be funded with a generous gift from the Shmunis family, enabling a leap in groundbreaking research. At the Shmunis School, researchers… Read More